Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Retatrutide's Phase 2 trial data (Jastreboff et al., NEJM 2023) identified a side-effect profile broadly consistent with other incretin-based therapies: Gastrointestinal : Nausea, vomiting, diarrhoea, and constipation were the most commonly reported adverse effects, particularly during dose escalation
This personalized strategy increases the likelihood of achieving sustained weight loss results while minimizing unnecessary dose escalation or medication switches
8 Nguyen et al 9 reported that 671,959 patients underwent gastric bypass procedures in the United States from 2003 to 2008
- Storage: Peptides are usually stored in the refrigerator once reconstituted with bacteriostatic water
